Early Bird pricing may be history, but the good news is the 2026 Drug and Medical Device Seminar is shaping up to be anything but ordinary. If you like smart people, sharp ideas, and a little Boston energy, you’re in the right place.
What’s New and Big This Year
From May 20–22 at The Westin Copley Place in Boston’s bustling Back Bay, you’ll dig into the topics everyone in the field is talking about:
- The newest twists on Federal Rule of Evidence 702 and expert challenges
- Global mass tort coordination and cross‑border strategy
- Hot‑button litigation trends like PFAS, ethylene oxide, and the push toward “clean pharma”
- Direct insights from medical device GCs, in‑house leaders, and regulatory voices who don’t sugarcoat anything
Plus, this year’s program adds fresh sessions on AI in litigation, jury persuasion, MDL strategy, and science‑driven defense themes. DRI’s programming is all designed to give you takeaways you can use the moment you’re back at your desk.
Networking That Actually Matters
This seminar draws the people who move the needle in drug and device defense. You’ll meet trial lawyers, in‑house counsel, scientists, and industry leaders tackling the same challenges you are. And with attendees from companies like AbbVie, Becton Dickinson, GSK, Medtronic, Sanofi, and Stryker, the conversations you have here can genuinely shift your practice.
Boston. May. Your Next Big Professional Boost.
Prices are already up now that Early Bird has closed, but you can still save up to $500. If you want in, lock it in.
Register here: https://bit.ly/4ssfwFL